About
At Veracyte, we offer exciting career opportunities for those interested in joining a pioneering team that is committed to transforming cancer care for patients across the globe. Working at Veracyte enables our employees to not only make a meaningful impact on the lives of patients, but to also learn and grow within a purpose driven environment. This is what we call the Veracyte way – it’s about how we work together, guided by our values, to give clinicians the insights they need to help pati...
Updates & Highlights
marketscreener.com · 1 day ago
Veracyte Adds Another Stream to Bladder Franchise, UBS Says
Investing.com · 1 day ago
Veracyte at Morgan Stanley conference: growth, deals and new tests
Investing.com South Africa · 1 day ago
Needham reiterates Veracyte stock rating at Buy on genomics deal By Investing.com
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Veracyte?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentVeracyte Adds Another Stream to Bladder Franchise, UBS Says
Veracyte Adds Another Stream to Bladder Franchise, UBS Says
marketscreener.com · 1 day ago
Veracyte at Morgan Stanley conference: growth, deals and new tests
Veracyte at Morgan Stanley conference: growth, deals and new tests
Investing.com · 1 day ago
Needham reiterates Veracyte stock rating at Buy on genomics deal By Investing.com
Needham reiterates Veracyte stock rating at Buy on genomics deal By Investing.com
Investing.com South Africa · 1 day ago
Needham reiterates Veracyte stock rating at Buy on genomics deal By Investing.com
Needham reiterates Veracyte stock rating at Buy on genomics deal By Investing.com
Investing.com Nigeria · 2 days ago
Veracyte buys Convergent Genomics to add urine-based bladder cancer test
Veracyte buys Convergent Genomics to add urine-based bladder cancer test
Dealroom · 2 days ago
Veracyte (NASDAQ: VCYT) director to sell $204,747 in shares
Veracyte (NASDAQ: VCYT) director to sell $204,747 in shares
Stock Titan · 2 days ago
Veracyte acquires Convergent Genomics for up to $180 million
Veracyte acquires Convergent Genomics for up to $180 million
Investing.com · 2 days ago
Veracyte Buys Convergent Genomics
Veracyte Buys Convergent Genomics
marketscreener.com · 2 days ago
Veracyte Acquires Convergent Genomics for $150 Million Cash Plus Up to $30 Million Earnout
Veracyte Acquires Convergent Genomics for $150 Million Cash Plus Up to $30 Million Earnout
TradingView · 2 days ago
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform
marketscreener.com · 2 days ago
Veracyte (VCYT) Gets a Buy from UBS
Veracyte (VCYT) Gets a Buy from UBS
The Globe and Mail · 7 days ago
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Yahoo Finance · 7 days ago
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies
Yahoo Finance Australia · 7 days ago
Veracyte Inc (VCYT) Shares Surge 3.3% -- What GF Score of 81 Tel
Veracyte Inc (VCYT) Shares Surge 3.3% -- What GF Score of 81 Tel
GuruFocus · 7 days ago
UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating
UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating
marketscreener.com · 8 days ago
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
Eastern Progress · 9 days ago
Chief Scientific & Medical Officer Of Veracyte Sold 33% Of Their Shares
Chief Scientific & Medical Officer Of Veracyte Sold 33% Of Their Shares
simplywall.st · 11 days ago
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares By Investing.com
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares By Investing.com
Investing.com South Africa · 12 days ago
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock
Investing.com Nigeria · 12 days ago
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares
Investing.com · 12 days ago